Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dravet Syndrome, Intractable”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)UnknownNCT05560282
What this trial is testing

Fenfluramine for Adult Dravet Patients

Who this might be right for
Dravet SyndromeDravet Syndrome, Intractable
University Health Network, Toronto 15
Not applicableAvailableNCT04457687
What this trial is testing

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Who this might be right for
Epilepsies, MyoclonicDrug Resistant Epilepsy
Eisai Inc.
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Large-scale testing (Phase 3)Looking for participantsNCT06872125
What this trial is testing

Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 170
Testing effectiveness (Phase 2)Study completedNCT04442295
What this trial is testing

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT04740476
What this trial is testing

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 60
Not applicableNo Longer AvailableNCT01533506
What this trial is testing

Stiripentol in Dravet Syndrome

Who this might be right for
Dravet Syndrome
Mayo Clinic
Large-scale testing (Phase 3)Active Not RecruitingNCT05064878
What this trial is testing

Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency DisorderGeneralized Tonic Clonic SeizureEpileptic Spasm+1 more
Zogenix, Inc. 87
Early research (Phase 1)UnknownNCT03024827
What this trial is testing

Cannabidiol in Children With Refractory Epileptic Encephalopathy

Who this might be right for
Epileptic Encephalopathy
University of Saskatchewan 20
Large-scale testing (Phase 3)Study completedNCT03572933
What this trial is testing

Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder

Who this might be right for
CDKL5 Deficiency Disorder
Marinus Pharmaceuticals 101